Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001193125-25-322740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-17 | 2025-12-15 | FULC | Oltmans Curtis Gale | CLO | S - Sale | $12.92 | -3,452 | 10.3K | -25% | -$44.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-15 | S | D | 3,452 | $12.92 | 10,252 | D | — | — | (F2) Includes 10,252 shares that were previously acquired under the Issuer's employee stock purchase plan. |